This may be from friends, family, or community groups. -, Molecular pathogenesis of chronic lymphocytic leukemia. 2001 Jun;15(6):981-6. doi: 10.1038/sj.leu.2402125. Fonseca R, Oken MM, Harrington D, Bailey RJ, Van Wier SA, Henderson KJ, Kay NE, Van Ness B, Greipp PR, Dewald GW. Dal Bo M, Rossi FM, Rossi D, Deambrogi C, Bertoni F, Del Giudice I, Palumbo G, Nanni M, Rinaldi A, Kwee I, Tissino E, Corradini G, Gozzetti A, Cencini E, Ladetto M, Coletta AM, Luciano F, Bulian P, Pozzato G, Laurenti L, Forconi F, Di Raimondo F, Marasca R, Del Poeta G, Gaidano G, Fo R, Guarini A, Gattei V. Genes Chromosomes Cancer. However, you may visit "Cookie Settings" to provide a controlled consent. These cells originate in the bone marrow. It is highly variable in size and develops in 30% of disease prolapse [4]. 2020;50(SI-2):1679-1690. doi:10.3906/sag-2005-327, Evans J, Ziebland S, Pettitt AR. CLL is uncommon in people under the age of 40. Interstitial 13q14 deletions detected in the karyotype and translocations with concomitant deletion at 13q14 in chronic lymphocytic leukemia: different genetic mechanisms but equivalent poorer clinical outcome. del(13q) is a favorable prognostic marker (median overall survival [OS], 17 years in one prospective study). having Binet stage B or C chronic lymphocytic leukaemia. CLL is not curable. -. It has been shown in studies to be as effective as aggressive treatments during early CLL stages. The authors have declared that no competing interests exist. CONCLUSION: In CLL with del(13q), a subset of patients progress after FCR therapy and have poor PFS. Learn about CLL diagnosis, staging, symptoms, and, Atypical chronic myeloid leukemia is a blood and bone marrow cancer. People with CLL may benefit from gentle exercise and following a healthy, balanced diet. (2022). Targeted therapy: Targeted drugs may also be used as a first-line CLL treatment. People with early-stage disease who are watching and waiting may find it stressful to not pursue treatment. An 87% 5-year survival rate means that around 87 out of every 100 people with CLL will be alive 5 years after diagnosis. In CLL, the most common DNA mutation is a deletion in chromosome 13 [del(13q)]. This site needs JavaScript to work properly. American Cancer Society. Theyll also take a medical history that includes information about your familys history of this disease. 4 100 80 60 40 20 0 . In the Rai system, a person will have blood tests to check for cancer cells and determine how many white blood cells are in the blood and bone marrow. Epub 2018 Apr 24. This figure is from an open-access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License. Paroxysmal nocturnal hemoglobinuria with deletion of chromosome 13q (q12q14): a case report and review of the literature. A huge reason for this is the identification of prognostic factors which throw more light into the heterogeneous biology of the disease. Other factors that can affect survival rates include: Treatment can help people manage CLL symptoms and improve their overall outlook. The RB1 gene is involved in the regulation of cell cycle progression and genomic stability. An 87% 5-year survival rate means that around 87 out of every 100 people with CLL will be alive 5 years after diagnosis. 2023 Dotdash Media, Inc. All rights reserved, Verywell Health uses only high-quality sources, including peer-reviewed studies, to support the facts within our articles. Bookshelf Epub 2017 Jun 6. Balanced translocations in parents are a rare cause of de novo RB1 deletions in offspring. Bethesda, MD 20894, Web Policies Despite the fact that only five patients (4 percent) were reported to be in poor health (the others being excellent, very good, good and fair), 62 percent said that CLL "somewhat to very much" affected their views on life expectancy. Patients with del(17p) or TP53 mutation respond well to targeted inhibitors of the B-cell receptor pathway and BCL-2 pathway, such as Ibrutinib and venetoclax respectively. Or, it may mean putting on makeup every day, even when you dont feel like getting out of bed. Understanding cancer statistics incidence, survival, mortality. However, hope is always possible. Chronic lymphocytic leukemia - cancer stat facts. 13q was the best bucket, 17p the worst, trisomy 12 and 11q in between, whatever those numbers and letters meant (see FISH test for dummies). Corey Whelan is a patient advocate with a decades-long background in reproductive health. ASH 2022: Dr. Talha Munir on How IGHV Mutation Status of Chronic Lymphocytic Leukemia (CLL) Affects Response to Combination Ibrutinib Plus Venetoclax, ASH 2022: Final Analysis of the Prospective Multicenter CLL2-Give Trial of Obinutuzumab, Ibrutinib, and Venetoclax in Untreated Patients with CLL with 17p Deletion/TP53Mutation, CLL Societys COVID-19 Update for the Week of February 20, 2023, Karen Jones on Warm Autoimmune Hemolytic Anemia and wAIHA Warriors, 4) Deletions on the short arm of chromosome 17 (del(17p)). Haematologica 99 (2014): 1350-1355. The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. SEER. It is important to understand that these prognostic factors were developed and studied in the era of chemoimmunotherapy. (2022). Gaidano G, Fo R, Dalla-Favera R. J Clin Invest. Treat on clinical trial or novel targeted inhibitor. Mutations driving CLL and their evolution in progression and relapse. Furthermore, the size of deletion of the long arm of chromosome 13 (13q) has a remarkable effect on its prognosis and therapeutic intervention. These are very much chronic leukemias just as much as a chronic lymphocytic leukemia or a chronic myeloid leukemia. It may sound clich, but incurable and untreatable are not the same thing. 2M >4 (HR 1.85, p=0.02), high WBC count (HR 1.55, p<0.01), Hb <10 gm/dL (p=0.01), unmated IGVH (HR 2.78, p=0.001), abnormal karyotype (HR 2.01, p=0.04), splenomegaly (HR 2.45, p=0.001), MRD positivity at 12 months (HR 2.87, p=0.01) had a significant negative impact on PFS. Dealing with an incurable illness is never easy. (. Vaccine therapy. Would you like email updates of new search results? 2017;2017:329337. doi:10.1186/1755-8166-7-3. What are the types of chronic lymphocytic leukemia? INTRODUCTION: Chronic lymphocytic leukemia (CLL) with deletion 13q (del13q) has historically better outcome after chemotherapy. Cookies collect information about your preferences and your devices and are used to make the site work as you expect it to, to understand how you interact with the site, and to show advertisements that are targeted to your interests. Getting emotional support and expressing feelings can help. The survival rate is the percentage of people in that group who still live with the disease 5 years on. Individuals showing 13q14 abnormalities have a relatively . When a person has lymphocytic leukemia, white blood cells become leukemia cells, which can spread into the blood and other parts of the body. These cookies ensure basic functionalities and security features of the website, anonymously. Leukemia. Do not use chemotherapy. 2013. Administration UD of VA Veterans Health. CLL Society is a registered 501(c)(3) tax-exempt nonprofit organization. In CLL, too many lymphocytes (a type of white blood cell) are produced from a single cell line (monoclonal). About half of CLL patients have this change. Incurable, invisible and inconclusive: watchful waiting for chronic lymphocytic leukaemia and implications for doctor-patient communication. Careers. I think saying you have a loss of an ATM gene is just another way of saying you have 11q deleted cll. MeSH Furthermore, the size of deletion of the long arm of chromosome 13 (13q) has a remarkable effect on its prognosis and therapeutic intervention. Strati P, Keating MJ, O'Brien SM, et al. Survival rates for leukemia have improved significantly over the past 40 years. -, Genes Chromosomes Cancer. An official website of the United States government. Abdul Rashid Shah, Tariq Muzzafar, Romana Asad, Christine B Peterson, Hagop M. Kantarjian, Alessandra Ferrajoli, William G Wierda, Jan A. Burger, Nitin Jain, Gautam Borthakur, Maliha Khan, Abhishek Chilkulwar, Brion Randolph, Lohith Gowda, Michael J Keating; Chronic Lymphocytic Leukemia with Deletion 13q: Prognostic Predictors and Outcome after Treatment with Fludarabine, Cyclophosphamide and Rituximab (FCR). SNP array analysis revealed the common deletion of a 15 Mb (13.3 to 14.3) region of 13q in 7 13q and 13q patients. Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. -, The mutational landscape of chronic lymphocytic leukemia and its impact on prognosis and treatment. Accessibility Adv Biol Regul. Summary. al. Necessary cookies are absolutely essential for the website to function properly. Some studies have shown that combination chemoimmunotherapy, containing alkylating agents may overcome the negative prognostic implications of del11q. 2020 Apr 28;10(4):45. doi: 10.1038/s41408-020-0310-9. 2016 Jan;55(1):16-24 Haider Z, Landfors M, Golovleva I, Erlanson M, Schmiegelow K, Flgstad T, Kanerva J, Norn-Nystrm U, Hultdin M, Degerman S. Blood Cancer J. See this image and copyright information in PMC. This website uses cookies to improve your experience while you navigate through the website. Whereas patients who have a 17p deletion, which affects p53 or 11q deletion, which affectsATM, these patients unfortunately have a worsened prognosis than patients who have no abnormalities. National Library of Medicine These cookies will be stored in your browser only with your consent. How Chronic Lymphocytic Leukemia (CLL) Is Staged, Small Lymphocytic Lymphoma: Overview and More, An Overview of Chronic Lymphocytic Leukemia, Major Differences Between Leukemia and Lymphoma. The sharp decline in life expectancy with time is largely due to the high percentage of older people in the group. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc. These include: Staging can help your doctor determine CLL prognosis and spread. Of 51 patients who experienced disease progression, there were 8 observed deaths. The Worlds Leading Authority for Chronic Lymphocytic Leukemia Patients, Support Groups |Newsletter Sign Up | Donate Now, Home CLL Information & Management Newly Diagnosed CLL Testing & Imaging Test Before Treat Prognostic Factors in CLL. There are several ways that someone who has CLL can support their health and well-being. Unable to load your collection due to an error, Unable to load your delegates due to an error, PI3K, phosphoinositide 3 kinases; BCR, B cell receptors; BTK, Bruton tyrosine kinase; BCL2, B cell lymphoma 2; Abs, antibodies; CAR-T, chimeric antigen receptor T cell; CLL, chronic lymphocytic leukemia Copyright/License LicenseeThe JSLTR, Japan. This site needs JavaScript to work properly. Epub 2013 Sep 5. Tests for chronic lymphocytic leukemia. Penn Medicine - Abramson Cancer Center. Therefore, if better treatments have become available in the following 5 years, people who have had a recent diagnosis may find the survival rates have improved. Epub 2014 Jun 10. (2018). 3 NCI data for that same time frame show a decline in the new case rate and death rate . When a doctor examines an individual at regular appointments, they have the chance to check for signs that CLL may be returning and treat it quickly. However, it is possible to live for 10 years or more after diagnosis. Patients with renal dysfunction can have falsely elevated levels and hence, caution must be interpreted in this particular situation. Federal government websites often end in .gov or .mil. Expression of miR-15a and miR-16-1 in patients with chronic lymphocytic leukemia. 23 July 2018. . A higher stage will often shorten a persons life expectancy. Stages I and II are intermediate-risk. We analyzed this group of patients treated with FCR to characterize the relationship between clinico-biological parameters and outcome. Doctors can very rarely cure CLL. The life expectancy corresponds to that of the normal population, which is why regular follow-ups are not recommended. -, MicroRNA dysregulation and multi-targeted therapy for cancer treatment. It does not store any personal data. What is the latest research on the form of cancer Jimmy Carter has? High levels of serum beta-2 microglobulin (B2M) (>3.5 mg/l) is associated with shorter response to treatment and overall survival. This segment encodes several proteins that regulate cell proliferation and the cell cycle, such as SMAD9 and RB1; both are involved in the signal transduction pathway of transforming growth factor-beta (TGF-, an important . 2 Monoallelic 13q14 deletions are present in nearly 70% of patients with CLL, while biallelic and . Survival rate for chronic lymphocytic leukemia. Data compiled by the National Cancer Institute (NCI) from 2011 to 2017 indicate that the five-year relative survival rate for CLL is 87.2%. CLL Societys tax ID number is 46-4131354. The site is secure. By fluorescence in situ hybridization (FISH), %age of cells having del(13q) ranged from 8-98% with median of 55.75%. The site is secure. How do doctors diagnose chronic lymphocytic leukemia? We also use third-party cookies that help us analyze and understand how you use this website. not having changes to the IGHV gene. Chronic lymphocytic leukemia. However, some patients experience treatment resistance or rapid relapses, and in particular, those harboring a 17p/TP53 deletion (del(17p)). Chronic B-cell leukemias and Agent Orange - public health. Researchers examine information about a group of people with a recent CLL diagnosis to find survival rates. CLL has a higher survival rate than many other cancers. 2 In this review, we discuss the various prognostic parameters in CLL, focusing on cytogenetics . Its median age at diagnosis ranges from 70 to 72 years, with a male predominance of roughly 2:1 cases [2,3]. CLL-IPI is an index that was designed to integrate existing clinical staging systems with biological and genetic information to refine and provide more specific information on prognosis. ~Del(13q) is one of the most common chromosomal abnormalities in CLL. The median survival times (the time by which point half of the patients are alive, the other half dead) for the groups with 17p deletion, 11q deletion, 12q trisomy, normal karyotype, and 13q deletion as the sole abnormality were 32, 79, 114 . No two people are alike. Is exercise more effective than medication for depression and anxiety? 2014 Sep;53(9):788-97. doi: 10.1002/gcc.22188. Cutting-edge treatments, including the use of monoclonal antibodies (mAbs, proteins made in a lab to fight infection) and targeted therapies (using drugs or other substances to identify and attack certain cancer cells), are helping people live longer and with fewer symptoms than in decades past. What to know about atypical chronic myeloid leukemia, What to know about the history of chronic myeloid leukemia, an increase in WBC levels and enlargement of lymph nodes, an increase in WBC and enlargement of lymph nodes, spleen, or liver, an increase in WBC levels, low number of red blood cells, enlargement of lymph node, spleen, or liver, an increase in WBC levels, low number of red blood cells and platelets, enlargement of lymph nodes, spleen, or liver, whether CLL has come back or improved with treatment, how cancer cells have spread in the bone marrow. The cookie is used to store the user consent for the cookies in the category "Analytics". The second type progresses more quickly and is typically to be more severe. Copyright 2023 by American Society of Hematology, 642. This deletion leads to the loss of important microRNAs which are involved in maintaining the critical balance of the apoptosis mechanism of cell death of B lymphocytes. 2018 Jun;181(5):604-613. doi: 10.1111/bjh.15239. Patients with chronic lymphocytic leukemia (CLL) with 13q deletion as the sole cytogenetic abnormality usually have a favorable outcome, but the frequency of the 13q14 deletion and its impact on the outcome of other B-cell chronic lymphoproliferative disorders (BCLPDs) remain unclear. The severity of the condition and the signs and symptoms depend on the size and location of the deletion and which genes are involved. Alongside a physical exam, this information can give one of five stages for CLL: A higher stage number means that CLL is impacting more of the body. Age, overall health, and response to treatment can all have an impact on your outlook and what you can expect. Theyll want to know about toxin exposure you may have had to herbicides, including Agent Orange. Chronic lymphocytic leukemia: Overview. Kantarjian: Pfizer: Research Funding; Amgen: Research Funding; Bristol-Meyers Squibb: Research Funding; ARIAD: Research Funding; Delta-Fly Pharma: Research Funding; Novartis: Research Funding. Key statistics for chronic lymphocytic leukemia. 2% is the magical number. Fluorescence in situ hybridization (FISH) based prognostic factors. Abstract. So now we go back to mutated and unmutated CLL. As such, the imbalance contributes towards B cells' immortality and, thus, CLL arises. When told I had chronic lymphocytic leukemia (CLL) four years ago, all I heard was "leukemia". Clipboard, Search History, and several other advanced features are temporarily unavailable. How Chronic Lymphocytic Leukemia (CLL) Is Treated, How Waldenstrom Macroglobulinemia Is Diagnosed and Treated, Rituxan (Rituximab) for Non-Hodgkin Lymphoma, CLL, and More, Smart Patients Chronic Lymphocytic Leukemia Community, Key statistics for chronic lymphocytic leukemia. Bethesda, MD 20894, Web Policies Blood tests. []del(17p) is associated with mutated TP53 and with poor response rates and short duration of response to the standard therapeutic options. Br J Haematol. When we say 17p deletion CLL, what we mean is that the short (petit) arm of chromosome 17 is missing. Once they occur, symptoms may include: The survival rate for CLL is better than for many other types of cancer. 13q14 deletion size and number of deleted cells both influence prognosis in chronic lymphocytic leukemia. Can diet help improve depression symptoms? Other common CLL changes include deletions in chromosomes 11 and 17 [del(11q) and del(17q)], and trisomy 12, which is an extra copy of chromosome 12. Features that often occur in people with . We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. Can poor sleep impact your weight loss goals? The term "chronic" in chronic lymphocytic leukemia comes from the fact that this leukemia typically progresses more slowly than other types of leukemia. Disclaimer. Fluorescence in situ hybridization (FISH) based prognostic factors. A subset of Binet stage A CLL patients with TP53 abnormalities and mutated IGHV genes have stable disease. Your doctor may first suspect you have CLL from routine blood test results. Schnaiter A, Stilgenbauer S. 17p deletion in chronic lymphocytic leukemia: risk stratification and therapeutic approach. Corey Whelan is a freelance writer specializing in health and wellness conntent. Originally published inThe CLL Tribune Q3 2017. Unable to load your collection due to an error, Unable to load your delegates due to an error. ~Trisomy 12 is considered an intermediate risk chromosomal aberration and its impact on therapeutic choices is presently unknown. The deletion of 6q is found in 163 cases with CLL (6% of all CLL cases with an abnormal karyotype). Dr. Manali Kamdar is the Clinical Director of Lymphoma Services and Assistant Professor of Medicine at the University of Colorado School of Medicine. Transcript: William Wierda, MD, PhD: We've done quite a bit of work with prognostic factors in CLL and looked at predictive markers for time-to-first-treatment, predictive markers for how . Dal Bo M, Rossi FM, Rossi D, Deambrogi C, Bertoni F, Del Giudice I, Palumbo G, Nanni M, Rinaldi A, Kwee I, Tissino E, Corradini G, Gozzetti A, Cencini E, Ladetto M, Coletta AM, Luciano F, Bulian P, Pozzato G, Laurenti L, Forconi F, Di Raimondo F, Marasca R, Del Poeta G, Gaidano G, Fo R, Guarini A, Gattei V. Genes Chromosomes Cancer. CLL accounts for around one-quarter of new leukemia cases. By Corey Whelan However, other factors also have an impact. However, survival rates for this cancer are good, particularly with early diagnosis and treatment. But opting out of some of these cookies may affect your browsing experience. 2018 Jun 21;131(25):2745-2760. doi:10.1182/blood-2017-09-806398. Epub 2014 Jun 10. It can also determine which treatments will be most effective. Medical News Today has strict sourcing guidelines and draws only from peer-reviewed studies, academic research institutions, and medical journals and associations. Nupam A. Patel, MD:When we look at flow cytometry and we get a population that is monoclonal and we're looking at a B-cell population which also expresses CD5, the 2 things that definitely come into mind are chronic lymphocytic leukemia [CLL] and mantle cell lymphoma. Trends in survival of chronic lymphocytic leukemia patients in Germany and the USA in the first decade of the twenty-first century. CLL Society Inc. is a patientcentric, physiciancurated nonprofit organization focused on patient education, support, and research. It's a weighted scoring system based on five risk factors with P53 having the highest score of 4. All rights reserved. Chromosome 13q Deletion Syndrome may present complications such as malnutrition due to feeding difficulties, delayed achievement of milestones, and reduced quality of life. 2016;9(1):28. doi:10.1186/s13045-016-0257-2, Parikh SA, Rabe KG, Kay NE, et al. 1454 Melrose Ave.Ste 1-247Chula Vista, CA 91911Send us a message. ATM is the gene located on the q arm of the 11th chromosome. government site. In Germany, the annual incidence in men is 7.4/100.000 and in women 4.8/100.000, and the median age of onset is between 70 and 75 years. The association between base line characteristics, 12 month minimal residual disease (MRD) status as detected by flow cytometry with PFS and OS was assessed using univariate Cox proportional hazards model on all patients. If the disease has affected the B cells, the person's life expectancy can range from 10 to . Around 85% of people with chronic lymphocytic leukemia (CLL) live for 5 or more years following diagnosis. 2011 Aug;50(8):633-43. doi: 10.1002/gcc.20885. Taking walks, swimming at the gym, and doing easygoing activities like window shopping can help you stay engaged and social. CLL has a five-year survival rate of around 83%, although it drops under 70% in those over 75. The treatments youre going through may also make you feel very tired, or ill. Youll probably have good days and bad days. This cookie is set by GDPR Cookie Consent plugin. First-line chemoimmunotherapy with FCR has induced long-term remissions and improvement in overall survival in fit patients with CLL with mutated IGHV. Patients with chronic lymphocytic leukemia (CLL) with 13q deletion as the sole cytogenetic abnormality usually have a favorable outcome, but the frequency of the 13q14 deletion and its impact on the outcome of other B-cell chronic lymphoproliferative disorders (BCLPDs) remain unclear. Men are slightly more likely to get this condition than women. The Rai system is most typically used in the United States, while the Binet system is more commonly used throughout Europe. Journal of Hematology & Oncology. Platelet count <50,000/l, bi-allelic del(13q) while showing a negative impact on PFS was not statistically significant. Source: Genomic Aberrations and Survival in CLL Probability of Survival from the Date of Diagnosis for the Five Genetic Categories Dohner, et al., NEJM . The pathogenic role of del(13q) in CLL has been related to lack of B-cell proliferation control allegedly determined by deletion of the DLEU2/ MIR15A/ MIR16-1 locus, which is known to contain negative regulators of the expression of the BCL2 gene (Cimmino et al., 2005; Klein et al., 2010). 2017 Aug;92:864-869. doi: 10.1016/j.biopha.2017.05.144. It is associated with rapid disease progression and a shorter progression free survival. A complete blood count may be used to count the number of lymphocytes in a blood sample. Lymphocytic leukemia begins in the white blood cells (WBC), known as lymphocytes. Beta-2 microglobulin is also important to calculate the CLL-IPI score for patients which has prognostic implications and will be discussed in the latter part of this review. High-risk patients with chronic lymphocytic leukemia (CLL) who have an 11q deletionsaid to be an adverse predictor of poor outcomescan have durable responses when . There are two different systems used for staging CLL. The most common abnormality is deletion of 13q, which occurs in over 50% of patients. and transmitted securely. Data from pts in the 3 studies were pooled (ibr pool, comparator pool) and analyzed based on whether or not their CLL/SLL had del11q. Verywell Health's content is for informational and educational purposes only. Most often this change is a deletion that is, loss of part of a chromosome. Landau D, Tausch E, Taylor-Weiner A, et al. These abnormal lymphocytes do not function as they should, impairing the bodys ability to fight infection. a little bit anemic, some blasts, high white count, platelets, marrow 2-3+ fibrosis, karyotype deletion 13q. So this was a patient originally here from Texas, because the counts had been okay had been kind of watched, had not . Some experts have also proposed it to be a tool that could assist in decision to initiate therapy. In summary, the landscape of CLL therapeutics has changed drastically over the last few years. Dhner H, Stilgenbauer S, Benner A, et al. Puiggros A, Venturas M, Salido M, Blanco G, Fernandez-Rodriguez C, Collado R, Valiente A, Ruiz-Xivill N, Carri A, Ortuo FJ, Luo E, Calasanz MJ, Ardanaz MT, Pin M, Talavera E, Gonzlez MT, Ortega M, Marugn I, Ferrer A, Gimeno E, Bellosillo B, Delgado J, Hernndez J, Hernndez-Rivas JM, Espinet B; Grupo Cooperativo Espaol de Citogentica Hematolgica (GCECGH); Grupo Espaol de Leucemia Linftica Crnica (GELLC). Chronic lymphocytic leukemia (CLL) is the most prevalent type of adult leukemia and is defined by a typical immunophenotype of mature B-cell markers (CD19, CD20[dim], CD23, sIg [dim]) with coexpression of the T-cell marker CD5. Deletion of 13q14 [del(13q)] is the most common cytogenetic change (50%) in chronic lymphoblastic leukemia (CLL), and it is a good prognostic factor if it is detected as a sole aberration by FISH.

Irish Female Body Type, Do Guinea Pigs Miss Their Babies, Articles C